These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators. Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256 [TBL] [Abstract][Full Text] [Related]
3. [Intravenous or subcutaneous heparin. What is better in deep venous thrombosis?]. MMW Fortschr Med; 2002 Jun; 144(26):55. PubMed ID: 12154485 [No Abstract] [Full Text] [Related]
4. Clinical experiences in the administration of a low molecular weight heparin (Fragmin, Kabi-Vitrum) to healthy volunteers and in the treatment of established deep venous thrombosis. Bratt GA; Törnebohm E; Johanson M; Aberg W; Granqvist S; Lockner D Acta Chir Scand Suppl; 1988; 543():96-100. PubMed ID: 2847465 [TBL] [Abstract][Full Text] [Related]
5. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin. Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312 [TBL] [Abstract][Full Text] [Related]
6. [Ultrasonographic diagnosis of venous thrombosis: color Doppler and power Doppler]. De Fabritiis A; Amato A Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):21-6. PubMed ID: 11253336 [TBL] [Abstract][Full Text] [Related]
7. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations. Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A Angiology; 2007; 58(3):316-22. PubMed ID: 17626986 [TBL] [Abstract][Full Text] [Related]
8. Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis. Riess H; Koppenhagen K; Tolle A; Kemkes-Matthes B; Gräve M; Patek F; Drexler M; Siemens HJ; Harenberg J; Weidinger G; Brom J; Haas S; Thromb Haemost; 2003 Aug; 90(2):252-9. PubMed ID: 12888872 [TBL] [Abstract][Full Text] [Related]
9. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes]. MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309 [No Abstract] [Full Text] [Related]
10. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group. Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025 [TBL] [Abstract][Full Text] [Related]
11. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism. Prandoni P; Carnovali M; Marchiori A; Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264 [TBL] [Abstract][Full Text] [Related]
12. Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with the fixed-dose body weight-independent low molecular weight heparin certoparin. Harenberg J; Huisman MV; Tolle AR; Breddin HK; Kirchmaier CM Semin Thromb Hemost; 2001 Oct; 27(5):513-8. PubMed ID: 11668421 [TBL] [Abstract][Full Text] [Related]
13. [Limits of clinical look. A 78-year-old patient with calf pain and lower leg swelling]. Thierfelder C Praxis (Bern 1994); 2004 Feb; 93(6):200-1. PubMed ID: 15008016 [No Abstract] [Full Text] [Related]
17. [Heparin after deep venous thrombosis. Even the first injection the patient can administer himself]. MMW Fortschr Med; 1999 Dec; 141(51-52):62. PubMed ID: 10949629 [No Abstract] [Full Text] [Related]
18. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?]. Ruiz Manzano J; Monreal M Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434 [No Abstract] [Full Text] [Related]
20. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination. Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]